LEARN HOW TO IDENTIFY
Symptoms include shortness of breath, fatigue and progressive tiredness
Published on December 4, 2025 at 05:00
Discover a serious disease that is confused with asthma, but overloads the heart and kills Credit: Shutterstock
Shortness of breath, fatigue and tiredness can be symptoms that point to a diagnosis of asthma, however, you need to be careful because there is a rare, progressive and serious disease that has the same symptoms, but can lead to death. This is pulmonar
pulmonary Arterial Hypertension: Understanding, Treatment, and Recent Discussions
Table of Contents
Pulmonary arterial hypertension (PAH) is a serious and progressive condition characterized by high blood pressure in the arteries of the lungs. This increased pressure puts a strain on the right side of the heart, perhaps leading to heart failure and significantly impacting quality of life. While there is currently no cure,advancements in treatment offer hope for managing symptoms and slowing disease progression. Recent discussions, such as a panel led by pulmonologist Camila Loureiro in Salvador, Brazil, sponsored by MSD, aim to increase awareness and disseminate crucial health information about this complex disease.
What is Pulmonary Arterial Hypertension?
Pulmonary hypertension refers to high blood pressure in the arteries that go from the heart to the lungs. PAH is a specific type of pulmonary hypertension.In PAH, the small arteries in the lungs become narrowed, thickened, or blocked. This makes it harder for blood to flow through, increasing the pressure. The heart then has to work harder to pump blood through the lungs, eventually leading to right heart failure.
According to the National heart, Lung, and Blood Institute (NHLBI), PAH is relatively rare, affecting an estimated 500 to 1,000 people per million.
Symptoms of PAH
Symptoms of PAH can be subtle at first and frequently enough mimic other conditions, making early diagnosis challenging. Common symptoms include:
* Shortness of breath, especially during exercise
* Fatigue
* Chest pain
* Dizziness or fainting
* Swelling in the ankles, legs, and abdomen
* Bluish color of the lips and skin (cyanosis)
Causes and Risk Factors
The cause of PAH is ofen unknown (idiopathic PAH). However, several factors can increase the risk of developing the condition:
* Genetics: A family history of PAH increases risk. Mutations in the BMPR2 gene are a common genetic link. Mayo Clinic details this further.
* Other Medical Conditions: PAH can be associated with conditions like:
* connective tissue diseases (e.g., scleroderma, lupus)
* HIV infection
* liver disease
* Congenital heart defects
* Certain medications and Toxins: Some drugs and exposure to certain toxins can contribute to PAH.
Diagnosis
Diagnosing PAH involves a combination of tests, including:
* Echocardiogram: An ultrasound of the heart to assess heart function and estimate pulmonary artery pressure.
* Pulmonary Function Tests: To evaluate lung capacity and airflow.
* Right Heart Catheterization: The gold standard for diagnosing PAH, this procedure directly measures pressures in the pulmonary arteries and heart. American Lung Association provides a detailed explanation.
* Blood tests: To rule out other causes of symptoms and assess overall health.
* Imaging Scans: CT scans or MRI can definitely help visualize the pulmonary arteries.
Treatment Options
While there is no cure for PAH, treatment focuses on managing symptoms, slowing disease progression, and improving quality of life. Treatment is typically managed by a specialist in pulmonary hypertension. Options include:
* Medications: Several classes of drugs are used to dilate blood vessels in the lungs, reducing pulmonary artery pressure.These include:
* Endothelin receptor antagonists (ERAs)
* Phosphodiesterase-5 (PDE5) inhibitors
* Prostacyclin analogs
* Soluble guanylate cyclase (sGC) stimulators
* Diuretics: To reduce fluid buildup.
* Anticoagulants: To prevent blood clots.
* Oxygen Therapy: to supplement oxygen levels.
* Lifestyle Changes: Regular exercise (as tolerated), a healthy diet, and avoiding smoking are crucial.
* Lung Transplant: In severe cases,a lung transplant may be considered.
Recent Discussions and Awareness Efforts
A recent panel discussion in Salvador,Brazil,led by pulmonologist Camila Loureiro and sponsored by MSD,highlighted the importance of raising awareness about PAH. These types of events are crucial for disseminating information to healthcare professionals and the public, ultimately leading to earlier diagnosis and improved patient care. MSD (https://www.msd.com/) is a global pharmaceutical company dedicated to developing and providing innovative health solutions.
Key Takeaways
* Pulmonary arterial hypertension is a serious condition affecting the arteries in the lungs.
Worth a look